دورية أكاديمية

Irreversible depletion of intestinal CD4+ T cells is associated with T cell activation during chronic HIV infection.

التفاصيل البيبلوغرافية
العنوان: Irreversible depletion of intestinal CD4+ T cells is associated with T cell activation during chronic HIV infection.
المؤلفون: Asowata OE; Africa Health Research Institute (AHRI), Durban, South Africa.; School of Laboratory Medicine and Medical Sciences, University of KwaZulu-Natal, Durban, South Africa., Singh A; Africa Health Research Institute (AHRI), Durban, South Africa., Ngoepe A; Africa Health Research Institute (AHRI), Durban, South Africa., Herbert N; Africa Health Research Institute (AHRI), Durban, South Africa., Fardoos R; Africa Health Research Institute (AHRI), Durban, South Africa.; Department of Immunology and Microbiology, University of Copenhagen, Denmark., Reddy K; Africa Health Research Institute (AHRI), Durban, South Africa., Zungu Y; Africa Health Research Institute (AHRI), Durban, South Africa., Nene F; Africa Health Research Institute (AHRI), Durban, South Africa., Mthabela N; Africa Health Research Institute (AHRI), Durban, South Africa., Ramjit D; Africa Health Research Institute (AHRI), Durban, South Africa., Karim F; Africa Health Research Institute (AHRI), Durban, South Africa., Govender K; Africa Health Research Institute (AHRI), Durban, South Africa., Ndung'u T; Africa Health Research Institute (AHRI), Durban, South Africa.; School of Laboratory Medicine and Medical Sciences, University of KwaZulu-Natal, Durban, South Africa.; University College London, Division of Infection and Immunity, London, United Kingdom.; Max Planck Institute for Infection Biology, Berlin, Germany., Porterfield JZ; Africa Health Research Institute (AHRI), Durban, South Africa.; Department of Microbiology, Immunology, and Molecular Genetics, University of Kentucky, Lexington, Kentucky, USA., Adamson JH; Africa Health Research Institute (AHRI), Durban, South Africa., Madela FG; Division Upper Gastrointestinal Tract and Colorectal Surgery, Inkosi Albert Luthuli Central Hospital (IALCH), University of KwaZulu-Natal, Durban, South Africa., Manzini VT; Division Upper Gastrointestinal Tract and Colorectal Surgery, Inkosi Albert Luthuli Central Hospital (IALCH), University of KwaZulu-Natal, Durban, South Africa., Anderson F; Division Upper Gastrointestinal Tract and Colorectal Surgery, Inkosi Albert Luthuli Central Hospital (IALCH), University of KwaZulu-Natal, Durban, South Africa., Leslie A; Africa Health Research Institute (AHRI), Durban, South Africa.; School of Laboratory Medicine and Medical Sciences, University of KwaZulu-Natal, Durban, South Africa.; University College London, Division of Infection and Immunity, London, United Kingdom., Kløverpris HN; Africa Health Research Institute (AHRI), Durban, South Africa.; School of Laboratory Medicine and Medical Sciences, University of KwaZulu-Natal, Durban, South Africa.; Department of Immunology and Microbiology, University of Copenhagen, Denmark.; University College London, Division of Infection and Immunity, London, United Kingdom.
المصدر: JCI insight [JCI Insight] 2021 Nov 22; Vol. 6 (22). Date of Electronic Publication: 2021 Nov 22.
نوع المنشور: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
اللغة: English
بيانات الدورية: Publisher: American Society for Clinical Investigation Country of Publication: United States NLM ID: 101676073 Publication Model: Electronic Cited Medium: Internet ISSN: 2379-3708 (Electronic) Linking ISSN: 23793708 NLM ISO Abbreviation: JCI Insight Subsets: MEDLINE
أسماء مطبوعة: Original Publication: Ann Arbor, Michigan : American Society for Clinical Investigation, [2016]-
مواضيع طبية MeSH: CD4-Positive T-Lymphocytes/*metabolism , HIV Infections/*immunology , Lymphocyte Activation/*immunology, Chronic Disease ; Humans
مستخلص: HIV infection in the human gastrointestinal (GI) tract is thought to be central to HIV progression, but knowledge of this interaction is primarily limited to cohorts within Westernized countries. Here, we present a large cohort recruited from high HIV endemic areas in South Africa and found that people living with HIV (PLWH) presented at a younger age for investigation in the GI clinic. We identified severe CD4+ T cell depletion in the GI tract, which was greater in the small intestine than in the large intestine and not correlated with years on antiretroviral treatment (ART) or plasma viremia. HIV-p24 staining showed persistent viral expression, particularly in the colon, despite full suppression of plasma viremia. Quantification of mucosal antiretroviral (ARV) drugs revealed no differences in drug penetration between the duodenum and colon. Plasma markers of gut barrier breakdown and immune activation were elevated irrespective of HIV, but peripheral T cell activation was inversely correlated with loss of gut CD4+ T cells in PLWH alone. T cell activation is a strong predictor of HIV progression and independent of plasma viral load, implying that the irreversible loss of GI CD4+ T cells is a key event in the HIV pathogenesis of PLWH in South Africa, yet the underlying mechanisms remain unknown.
References: PLoS Med. 2008 Oct 21;5(10):e203. (PMID: 18942885)
J Infect Dis. 2016 Oct 1;214 Suppl 2:S58-66. (PMID: 27625432)
J Virus Erad. 2016;2:43-48. (PMID: 26889497)
Immunity. 2017 Apr 18;46(4):532-548. (PMID: 28423335)
Semin Immunol. 2008 Jun;20(3):181-6. (PMID: 18595731)
PLoS One. 2012;7(2):e30881. (PMID: 22363505)
Lancet. 2013 Nov 2;382(9903):1525-33. (PMID: 24152939)
HIV Clin Trials. 2009 Sep-Oct;10(5):324-7. (PMID: 19906625)
Nat Med. 2006 Dec;12(12):1365-71. (PMID: 17115046)
J Immunol. 1992 Oct 15;149(8):2816-22. (PMID: 1383328)
Clin Infect Dis. 2012 Apr;54(7):984-94. (PMID: 22337823)
Sci Immunol. 2019 Dec 6;4(42):. (PMID: 31811055)
J Infect Dis. 2016 Oct 1;214 Suppl 2:S44-50. (PMID: 27625430)
J Infect Dis. 2014 Oct 15;210(8):1248-59. (PMID: 24795473)
J Infect Dis. 2011 Mar 15;203(6):780-90. (PMID: 21252259)
N Engl J Med. 2015 Aug 27;373(9):795-807. (PMID: 26192873)
JAMA Intern Med. 2013 Apr 22;173(8):614-22. (PMID: 23459863)
Immunol Rev. 2013 Jul;254(1):343-54. (PMID: 23772630)
J Acquir Immune Defic Syndr. 2013 Jul;63 Suppl 2:S240-7. (PMID: 23764642)
Sci Transl Med. 2011 Dec 7;3(112):112re4. (PMID: 22158861)
HIV Med. 2016 Apr;17(4):255-68. (PMID: 26216031)
N Engl J Med. 1998 Mar 26;338(13):853-60. (PMID: 9516219)
J Infect Dis. 2013 Oct 15;208(8):1212-20. (PMID: 23852128)
Cell. 2018 Nov 15;175(5):1307-1320.e22. (PMID: 30392957)
Blood. 2004 Aug 15;104(4):942-7. (PMID: 15117761)
Clin Gastroenterol Hepatol. 2018 Feb;16(2):190-197.e11. (PMID: 28603049)
PLoS Pathog. 2013;9(5):e1003347. (PMID: 23671416)
Nature. 2019 Dec;576(7787):397-405. (PMID: 31853080)
BMC Infect Dis. 2019 Jun 7;19(1):500. (PMID: 31174475)
S Afr Med J. 2017 Jul 28;107(8):706-709. (PMID: 28809620)
J Int AIDS Soc. 2012 Oct 10;15(2):17426. (PMID: 23078769)
J Clin Pathol. 1989 Mar;42(3):275-81. (PMID: 2703544)
AIDS. 2013 Jun 1;27(9):1413-9. (PMID: 23945503)
Lancet HIV. 2018 Aug;5(8):e427-e437. (PMID: 30021700)
J Exp Med. 2004 Sep 20;200(6):749-59. (PMID: 15365096)
Curr Opin HIV AIDS. 2018 Mar;13(2):137-142. (PMID: 29232209)
Lancet HIV. 2018 Jan;5(1):e35-e44. (PMID: 28978417)
Nature. 2005 Apr 28;434(7037):1093-7. (PMID: 15793563)
Clin Infect Dis. 2011 Dec;53(11):1120-6. (PMID: 21998278)
Virology. 2014 Sep;464-465:253-263. (PMID: 25105490)
World J Gastroenterol. 2018 Feb 21;24(7):767-774. (PMID: 29467548)
Ann Intern Med. 1984 Oct;101(4):421-8. (PMID: 6476631)
Nature. 1987 Apr 16-22;326(6114):711-3. (PMID: 3031512)
Clin Vaccine Immunol. 2006 May;13(5):556-60. (PMID: 16682476)
J Infect Dis. 2015 Apr 1;211(7):1068-75. (PMID: 25344521)
Clin Infect Dis. 2019 Aug 1;69(4):639-647. (PMID: 30476001)
Nat Med. 2017 Nov;23(11):1271-1276. (PMID: 28967921)
J Acquir Immune Defic Syndr. 2018 May 1;78(1):82-92. (PMID: 29424790)
J Infect Dis. 2017 Oct 17;216(7):813-818. (PMID: 28968888)
Clin Microbiol Rev. 2013 Jan;26(1):2-18. (PMID: 23297256)
J Virol. 2003 Nov;77(21):11708-17. (PMID: 14557656)
Proc Natl Acad Sci U S A. 2014 Feb 11;111(6):2307-12. (PMID: 24469825)
BMJ. 2009 Jan 26;338:a3172. (PMID: 19171560)
J Acquir Immune Defic Syndr. 2016 Jun 1;72(2):230-6. (PMID: 26890283)
PLoS Med. 2006 Dec;3(12):e484. (PMID: 17147468)
Sci Transl Med. 2019 Jul 3;11(499):. (PMID: 31270274)
J Infect Dis. 2014 Oct 15;210(8):1228-38. (PMID: 24755434)
EBioMedicine. 2016 Sep;11:68-72. (PMID: 27460436)
J Acquir Immune Defic Syndr. 2010 Nov;55(3):316-22. (PMID: 20581689)
Clin Infect Dis. 2017 Jan 15;64(2):124-131. (PMID: 27737952)
Intern Med. 2016;55(19):2881-2884. (PMID: 27725553)
Retrovirology. 2007 Dec 04;4:87. (PMID: 18053211)
Clin Pharmacol Ther. 2020 Nov;108(5):971-975. (PMID: 32385902)
Nat Protoc. 2008;3(7):1240-8. (PMID: 18600229)
Antimicrob Agents Chemother. 2016 Apr 22;60(5):2771-81. (PMID: 26902756)
Nat Med. 2005 May;11(5):469-70. (PMID: 15875046)
South Afr J HIV Med. 2017 Jul 15;18(1):776. (PMID: 29568644)
AIDS. 2007 Oct 1;21(15):2106-8. (PMID: 17885303)
J Virol. 2006 Aug;80(16):8236-47. (PMID: 16873279)
PLoS Med. 2015 Mar 31;12(3):e1001809. (PMID: 25826420)
Lancet Infect Dis. 2016 May;16(5):565-575. (PMID: 26831472)
Science. 1998 Apr 17;280(5362):427-31. (PMID: 9545219)
BMC Infect Dis. 2014 Mar 04;14:122. (PMID: 24589015)
Clin Infect Dis. 2007 Dec 15;45(12):1593-601. (PMID: 18190322)
Immunity. 2013 Oct 17;39(4):633-45. (PMID: 24138880)
Anal Chem. 2011 Nov 15;83(22):8604-10. (PMID: 22035192)
J Infect Dis. 2010 Sep 1;202(5):723-33. (PMID: 20629534)
J Immunol. 2010 Nov 1;185(9):5169-79. (PMID: 20889546)
PLoS Pathog. 2014 Dec 11;10(12):e1004543. (PMID: 25503054)
J Infect Dis. 2008 Mar 1;197(5):714-20. (PMID: 18260759)
J Exp Med. 2004 Sep 20;200(6):761-70. (PMID: 15365095)
معلومات مُعتمدة: United Kingdom WT_ Wellcome Trust; R01 DK126545 United States DK NIDDK NIH HHS; 202485/Z/16/Z United Kingdom WT_ Wellcome Trust; 210662/Z/18/Z United Kingdom WT_ Wellcome Trust; 107752/Z/15/Z United Kingdom WT_ Wellcome Trust
فهرسة مساهمة: Keywords: AIDS/HIV; Gastroenterology; T cells
تواريخ الأحداث: Date Created: 20211007 Date Completed: 20220307 Latest Revision: 20220307
رمز التحديث: 20240829
مُعرف محوري في PubMed: PMC8663780
DOI: 10.1172/jci.insight.146162
PMID: 34618690
قاعدة البيانات: MEDLINE
الوصف
تدمد:2379-3708
DOI:10.1172/jci.insight.146162